Celldex Therapeutics Inc (CLDX)
Cost of Revenue
$63.79M
TTM · Period ending: · USD
CLDX Cost of Revenue
Latest reported$63.79Mperiod ending
Latest reported$63.79Mperiod ending
CLDX TTM Cost of Revenue ($0.00 → $63.79M)
TTM cost of revenue
High-resolution chart · PNG
CLDX cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 63,785,000 | |
| 117,981,000 | |
| 169,741,000 | |
| 170,560,000 | |
| 152,892,000 | |
| 99,493,000 | |
| 47,654,000 | |
| 77,261,000 | |
| 32,765,000 | |
| 58,220,000 | |
| 84,243,000 | |
| 76,716,000 | |
| 97,521,000 | |
| 92,000,000 | |
| 82,258,000 | |
| 74,037,000 | |
| 66,022,000 | |
| 57,647,000 | |
| 53,311,000 | |
| 49,058,000 | |
| 46,209,000 | |
| 43,558,000 | |
| 42,533,000 | |
| 42,447,000 | |
| 42,840,000 | |
| 43,216,000 | |
| 42,672,000 | |
| 42,540,000 | |
| 43,357,000 | |
| 54,724,000 | |
| 65,448,000 | |
| 78,705,000 | |
| 88,702,000 | |
| 92,253,000 | |
| 96,171,000 | |
| 72,708,000 | |
| 99,660,000 | |
| 124,230,000 | |
| 149,742,000 | |
| 77,481,000 | |
| -42,890,000 | |
| -162,129,000 | |
| -284,469,000 | |
| -185,183,000 | |
| -87,494,000 | |
| 6,276,000 | |
| 101,881,000 | |
| 39,348,000 | |
| -4,261,000 | |
| -51,112,000 | |
| -73,348,000 | |
| -34,290,000 | |
| -13,860,000 | |
| 10,764,000 | |
| 10,774,000 | |
| 9,581,000 | |
| 8,893,000 | |
| 8,961,000 | |
| 9,119,000 | |
| 13,561,000 | |
| 12,461,000 | |
| 12,252,000 | |
| 12,077,000 | |
| 13,674,000 | |
| 12,456,000 | |
| 10,724,000 | |
| 8,397,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 4,958,702 | |
| 4,958,702 | |
| 4,958,702 | |
| 9,917,404 | |
| 4,958,702 | |
| 4,958,702 | |
| 4,958,702 | |
| 4,348,707 | |
| 4,348,707 | |
| 4,348,707 | |
| 4,348,707 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 10,300 | |
| 27,300 | |
| 41,000 | |
| 51,100 | |
| 49,200 | |
| 40,400 | |
| -507,600 | |
| -699,100 |